Viatris (VTRS) Goodwill & Intangibles (2019 - 2026)
Viatris (VTRS) posted Goodwill & Intangibles of $20.3 billion for Q2 2026, down 3.98% on a QoQ basis from $21.2 billion in Q1 2026, and down 11.88% year-over-year from $23.1 billion in Q2 2025.
Analysis
Viatris (VTRS) Goodwill & Intangibles (2019 - 2026) Analysis & Trends
Viatris has reported Goodwill & Intangibles for 8 years, with the latest figure at $20.3 billion in Q2 2026.
- On a quarterly basis, Goodwill & Intangibles fell 11.88% year-over-year to $20.3 billion in Q2 2026; TTM through Jun 2026 was $20.3 billion, a 11.88% decrease from a year earlier, with the FY2025 full-year figure at $21.9 billion, down 16.59% from the prior year.
- Goodwill & Intangibles was $20.3 billion for Q2 2026 at Viatris, down from $21.2 billion in the prior quarter.
- The five-year high for Goodwill & Intangibles was $36.2 billion in Q1 2022, with the low at $20.3 billion in Q2 2026.
- Average Goodwill & Intangibles over 5 years is $28.1 billion, with a median of $28.3 billion recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Goodwill & Intangibles declined 4.56% in 2023, then declined 19.78% in 2025.
- Over 5 years, Goodwill & Intangibles stood at $33.0 billion in 2022, then fell by 12.06% to $29.0 billion in 2023, then fell by 9.79% to $26.2 billion in 2024, then retreated by 16.59% to $21.9 billion in 2025, then declined by 6.98% to $20.3 billion in 2026.
- The last three Goodwill & Intangibles figures came in at $20.3 billion (Q2 2026), $21.2 billion (Q1 2026), and $21.9 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.33 Bn |
| Mar 31, 2026 | 21.17 Bn |
| Dec 31, 2025 | 21.86 Bn |
| Sep 30, 2025 | 22.45 Bn |
| Jun 30, 2025 | 23.07 Bn |
| Mar 31, 2025 | 23.12 Bn |
| Dec 31, 2024 | 26.20 Bn |
| Sep 30, 2024 | 27.54 Bn |
| Jun 30, 2024 | 27.74 Bn |
| Mar 31, 2024 | 28.83 Bn |
| Dec 31, 2023 | 29.05 Bn |
| Sep 30, 2023 | 31.56 Bn |
| Jun 30, 2023 | 32.62 Bn |
| Mar 31, 2023 | 33.27 Bn |
| Dec 31, 2022 | 33.03 Bn |
| Sep 30, 2022 | 33.07 Bn |
| Jun 30, 2022 | 34.62 Bn |
| Mar 31, 2022 | 36.23 Bn |
| Dec 31, 2021 | 38.25 Bn |
| Sep 30, 2021 | 39.16 Bn |